Blood cancers, Myeloma
Results
Phase 4
This trial compared apixaban with other blood thinning medications to see if it works as well and whether it has fewer side effects.
It was open for people to join between 2016 and 2017, and the team published the results in 2019.
Recruitment start: 1 April 2016
Recruitment end: 4 April 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Roopen Arya
King’s College Hospital NHS Foundation Trust,
National Institute for Health Research (NIHR)
NIHR Clinical Research Network: Cancer
Last reviewed: 18 June 2020
CRUK internal database number: 13795
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
